There is increasing evidence suggesting that the neurotransmitter γ-aminobutyric acid (GABA) is a local factor involved in the regulation of endocrine organs. Examples of such functions are documented in the pancreas, but recent results suggest that GABA may act in a similar way in the pituitary, in which GABA receptors are expressed and pituitary growth hormone (GH) cells provide a source of GABA. We hypothesised that GABA secreted in somatotropes may act as an autoregulatory signaling molecule. To test this hypothesis we first examined the nature of GABA receptors expressed by GH cells. RT-PCR analysis demonstrated that GABA-B receptor subunits R1 and R2 are present in the whole rat pituitary. Laser microdissection of immunostained GH cells, followed by RT-PCR as well as immunoelectron microscopy, showed that GABA-B receptors are expressed on somatotropes. To investigate GABA-B receptor function in somatotropes, we used rat GH3 adenoma cells, which, like pituitary GH cells, express GABA-B R1 and R2 (as assessed by RT-PCR and immunoelectron microscopy) and produce GABA (checked by high performance liquid chromatography). After inhibition of endogenous GABA synthesis, GH production was stimulated by baclofen, a chromatography). After inhibition of endogenous GABA synthesis, GH production was stimulated by baclofen, a GABA-B receptor agonist. By contrast, blocking GABA-B receptors by an antagonist, phaclofen, decreased GH levels. We conclude that in GH-producing cells, GABA acts as an autocrine factor via GABA-B receptors to control GH levels.

1.
Makara GB, Stark E: Effects of γ-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release. Neuroendocrinology 1974;16:178–190.
2.
Tomiko SA, Taraskevich PS, Douglas WW: GABA acts directly on cells of pituitary pars intermedia to alter hormone output. Nature 1983;301:706–707.
3.
Acs Z, Szabo B, Kapocs G, Makara GB: γ-Aminobutyric acid stimulates pituitary growth hormone secretion in the neonatal rat. A superfusion study. Endocrinology 1987;120:1790–1798.
4.
Tapia-Arancibia L, Roussel JP, Astier H: Evidence for a dual effect of γ-aminobutyric acid on thyrotropin (TSH)-releasing hormone-induced TSH release from perifused rat pituitaries. Endocrinology 1987;121:980–986.
5.
Virmani MA, Stojilkovic SS, Catt KJ: Stimulation of luteinizing hormone release by γ-aminobutyric acid (GABA) agonists: Mediation by GABAA-type receptors and activation of chloride and voltage-sensitive calcium channels. Endocrinology 1990;126:2499–2505.
6.
Lux-Lantos V, Rey E, Libertun C: Activation of GABA B receptors in the anterior pituitary inhibits prolactin and luteinizing hormone secretion. Neuroendocrinology 1992;56:687–693.
7.
Anderson RA, Mitchell R: Effects of γ-aminobutyric acid receptor agonists on the secretion of growth hormone, luteinizing hormone, adrenocorticotrophic hormone and thyroid-stimulating hormone from the rat pituitary gland in vitro. J Endocrinol 1986;108:1–8.
8.
Jung H, Shannon EM, Fritschy JM, Ojeda SR: Several GABAA receptor subunits are expressed in LHRH neurons of juvenile female rats. Brain Res 1998;780:218–229.
9.
Keen KL, Burich AJ, Mitsushima D, Kasuya E, Terasawa E: Effects of pulsatile infusion of the GABA(A) receptor blocker bicuculline on the onset of puberty in female rhesus monkeys. Endocrinology 1999;140:5257–5266.
10.
Vincent SR, Hökfelt T, Wu JY: GABA neuron systems in hypothalamus and the pituitary gland. Immunohistochemical demonstration using antibodies against glutamate decarboxylase. Neuroendocrinology 1982;34:117–125.
11.
Schimchowitsch S, Vuillez P, Tappaz ML, Klein MJ, Stoeckel ME: Systematic presence of GABA-immunoreactivity in the tubero-infundibular and tubero-hypophyseal dopaminergic axonal systems: An ultrastructural immunogold study on several mammals. Exp Brain Res 1991;83:575–586.
12.
Mayerhofer A, Höhne-Zell B, Gamel-Didelon K, Jung H, Redecker P, Grube D, Urbanski HF, Gasnier B, Fritschy JM, Gratzl M: γ-Aminobutyric acid (GABA): A para- and/or autocrine hormone in the pituitary. FASEB J 2001;15:1089–1091.
13.
Berman JA, Roberts JL, Pritchett DB: Molecular and pharmacological characterization of GABAA receptors in the rat pituitary. J Neurochem 1994;63:1948–1954.
14.
Boue-Grabot E, Dufy B, Garret M: Molecular diversity of GABA-gated chloride channels in the rat anterior pituitary. Brain Res 1995;704:125–129.
15.
Boue-Grabot E, Taupignon A, Tramu G, Garret M: Molecular and electrophysiological evidence for a GABAc receptor in thyrotropin-secreting cells. Endocrinology 2000;141:1627–1632-
16.
Rey-Roldan EB, Lux-Lantos AR, Gonzalez-Iglesias AE, Becu-Villalobos D, Libertun C: Baclofen, a γ-aminobutyric acid B agonist, modifies hormonal secretion in pituitary cells from infantile female rats. Life Sci 1996;58:1059–1065.
17.
Rey-Roldan EB, Lux-Lantos V, Chamson-Reig A, Libertun C: In vivo interaction of baclofen, TRH and serotonin on PRL and TSH secretion in the developing and adult male and female rats. Life Sci 1997;62:2283–2290.
18.
Lux-Lantos V, Becu-Villalobos D, Bianchi M, Rey-Roldan E, Chamson-Reig A, Pignataro O, Libertun C: GABA(B) receptors in anterior pituitary cells. Mechanism of action coupled to endocrine effects. Neuroendocrinology 2001;73:334–343.
19.
Tashjian AH Jr, Bancroft FC, Levine L: Production of both prolactin and growth hormone by clonal strains of rat pituitary tumor cells. Differential effects of hydrocortisone and tissue extracts. J Cell Biol 1970;47:61–70.
20.
Lahr G, Mayerhofer A, Bucher S, Barthels D, Wille W, Gratzl M: Neural cell adhesion molecules in rat endocrine tissues and tumor cells: Distribution and molecular analysis. Endocrinology 1993;132:1207–1217.
21.
Rosenstein RE, Chuluyan HE, Pereyra EN, Cardinali DP: Release and effect of γ-aminobutyric acid (GABA) on rat pineal melatonin production in vitro. Cell Mol Neurobiol 1989;9:207–219.
22.
Mayerhofer A, Dissen GA, Parrott JA, Hill DF, Mayerhofer D, Garfield RE, Costa ME, Skinner MK, Ojeda SR: Involvement of nerve growth factor in the ovulatory cascade: trkA receptor activation ihibits gap junctional communication between thecal cells. Endocrinology 1996;137:5662–5670.
23.
Frungieri MB, Urbanski HF, Hohne-Zell B, Mayerhofer A: Neuronal elements in the testis of the rhesus monkey: Ontogeny, characterization and relationship to testicular cells. Neuroendocrinology 2000;71:43–50.
24.
Mayerhofer A, Smith GD, Danilchik M, Levine JE, Wolf DP, Dissen GA, Ojeda SR: Oocytes are a source of catecholamines in the primate ovary: Evidence for a cell-cell regulatory loop. Proc Natl Acad Sci USA 1998;95:10990–10995.
25.
Mayerhofer A, Hemmings HC Jr, Snyder GL, Greengard P, Boddien S, Berg U, Brucker C: Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro. J Clin Endocrinol Metab 1999;84:257–264.
26.
Bulling A, Berg FD, Berg U, Duffy DM, Stouffer RL, Ojeda SR, Gratzl M, Mayerhofer A: Identification of an ovarian voltage-activated Na+-channel type: Hints to involvement in luteolysis. Mol Endocrinol 2000;14:1064–1074.
27.
Höhne-Zell B, Gratzl M: Adrenal chromaffin cells contain functionally different SNAP-25 monomers and SNAP-25/syntaxin heterodimers. FEBS Lett 1996;394:109–116.
28.
Mayerhofer A, Russell LD, Grothe C, Rudolf M, Gratzl M: Presence and localization of a 30-kDa basic fibroblast growth factor-like protein in rodent testes. Endocrinology 1991;129:921–924.
29.
Mayerhofer A, Lahr G, Gratzl M: Expression of the neural cell adhesion molecule in endocrine cells of the ovary. Endocrinology 1991;129:792–800.
30.
Melani A, Pantoni L, Corsi C, Bianchi L, Monopoli A, Bertorelli R, Pepeu G, Pedata F: Striatal outflow of adenosine, excitatory amino acids, γ-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: Correlations with neurological deficit and histopathological damage. Stroke 1999,30:2448–2454.
31.
Pinilla L, Gonzalez LC, Tena-Sempere M, Agular E: Cross-talk between excitatory and inhibitory amino acids in the regulation of growth hormone secretion in neonatal rats. Neuroendocrinology 2001;73:62–67.
32.
Pinilla L, Gonzalez LC, Tena-Sempere M, Aguilar E: 5-HT1 and 5-HT2 receptor agonists blunt +/– α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)-stimulated GH secretion in prepubertal male rats. Eur J Endocrinol 2001;144:535–541.
33.
McFerran DW, Stirland JA, Norris AJ, Khan RA, Takasuka N, Seymour ZC, Gill MS, Robertson WR, Loudon AS, Davis JR, White MR: Persistent synchronized oscillations in prolactin gene promoter activity in living pituitary cells. Endocrinology 2001;142:3255–3260.
34.
Louiset E, MCKernan R, Sieghart W, Vaudry H: Subunit composition and pharmacological characterization of γ-aminobutyric acid type A receptors in frog pituitary melanotrophs. Endocrinology 2000;141:1083–1092.
35.
Bianchi M, Rey-Roldan E, Bettler B, Ristig D, Malitschek B, Libertun C, Lux-Lantos V: Ontogenic expression of anterior pituitary GABA(B) receptor subunits. Neuropharmacology 2001;40:185–192.
36.
Chronwall BM, Davis TD, Severidt MW, Wolfe SE, McCarson KE, Beatty DM, Low MJ, Morris SJ, Enna SJ: Constitutive expression of functional GABA(B) receptors in mIL-tsA58 cells requires both GABA(B(1)) and GABA(B(2)) genes. J Neurochem 2001;77:1237–1247.
37.
Schutze K, Lahr G: Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol 1998;16:737–742.
38.
Frungieri MB, Calandra RS, Lustig L, Meineke V, Köhn FM, Vogt H-J, Mayerhofer A: Macrophages in the testes of infertile men: Number, distribution pattern and identification of expressed genes by laser microdissection and RT-PCR analysis. Fertil Steril, in press.
39.
Grosse J, Bulling A, Brucker C, Berg U, Amsterdam A, Mayerhofer A, Gratzl M: Synaptosome-associated protein of 25 kilodaltons in oocytes and steroid-producing cells of rat and human ovary: Molecular analysis and regulation by gonadotropins. Biol Reprod 2000;63:643–650
40.
Monteleone P, Maj M, Iovino M, Steardo L: Evidence for a sex difference in the basal growth hormone response to GABAergic stimulation in humans. Acta Endocrinol (Copenh.) 1988;119:353–357.
41.
Orio F Jr, Palomba S, Colao A, Tenuta M, Dentico C, Petretta M, Lombardi G, Nappi C, Orio F: Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women. Horm Res 2001;55:131–136.
42.
Rorsman P, Berggren PO, Bokvist K, Ericson H, Mohler H, Ostenson CG, Smith PA: Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 1989;341:233–236.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.